Free Trial
LON:SVCT

Seneca Growth Capital VCT Final Earnings Report

GBX 44 0.00 (0.00%)
As of 06/3/2026

Seneca Growth Capital VCT EPS Results

Actual EPS
-GBX 0.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Seneca Growth Capital VCT Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Seneca Growth Capital VCT Announcement Details

Quarter
Final
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Seneca Growth Capital VCT Earnings Headlines

Seneca Growth Capital VCT PLC B (SVCT)
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel
Seneca Growth Capital VCT B (SVCT.L)
B Share Net Asset Value
See More Seneca Growth Capital VCT Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seneca Growth Capital VCT? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seneca Growth Capital VCT and other key companies, straight to your email.

About Seneca Growth Capital VCT

Seneca Growth Capital VCT (LON:SVCT) is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.

View Seneca Growth Capital VCT Profile